Prospective multicenter trial: Hormonal changes by switching from GnRH agonist to GnRH antagonist in patients with early stage of castration resistant prostate cancer as a second line hormonal therapy
العنوان: | Prospective multicenter trial: Hormonal changes by switching from GnRH agonist to GnRH antagonist in patients with early stage of castration resistant prostate cancer as a second line hormonal therapy |
---|---|
المؤلفون: | Akitoshi Takizawa, Junichi Ohta, Kazuki Kobayashi, Yumiko Yokomizo, Masahiro Yao, Narihiko Hayashi, Kazuo Kitami, Takeshi Kishida, Hiroji Uemura |
المصدر: | Journal of Clinical Oncology. 36:e17030-e17030 |
بيانات النشر: | American Society of Clinical Oncology (ASCO), 2018. |
سنة النشر: | 2018 |
مصطلحات موضوعية: | Agonist, Oncology, endocrine system, Cancer Research, medicine.medical_specialty, medicine.drug_class, business.industry, GnRH Antagonist, medicine.disease, Prostate cancer, Internal medicine, Multicenter trial, medicine, Hormonal therapy, Progression-free survival, Stage (cooking), business, hormones, hormone substitutes, and hormone antagonists, Hormone |
الوصف: | e17030Background: It was reported that GnRH antagonist could extend progression free survival for prostate cancer patients significantly longer than GnRH agonist in a first line hormonal therapy. H... |
تدمد: | 1527-7755 0732-183X |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::f7040b9578b41160b8d61972a19e2639 https://doi.org/10.1200/jco.2018.36.15_suppl.e17030 |
رقم الأكسشن: | edsair.doi...........f7040b9578b41160b8d61972a19e2639 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 15277755 0732183X |
---|